Showing 35,521 - 35,540 results of 125,008 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 1.31s Refine Results
  1. 35521

    Data_Sheet_1_Cyclooxygenase-2 Facilitates Newcastle Disease Virus Proliferation and Is as a Target for Canthin-6-One Antiviral Activity.docx by Chongyang Wang (1446037)

    Published 2020
    “…However, prostaglandin E<sub>2</sub> (PGE<sub>2</sub>), the major product of COX-2, had indistinctive effects on NDV proliferation. At variant time point post viral infection, a tight regulation pattern of COX-2 by NDV was observed. …”
  2. 35522
  3. 35523
  4. 35524
  5. 35525
  6. 35526
  7. 35527
  8. 35528
  9. 35529
  10. 35530
  11. 35531

    DataSheet1_Bridging Legends and Science: Field Evidence of a Large Tsunami that Affected the Kingdom of Tonga in the 15th Century.pdf by Franck Lavigne (9951979)

    Published 2021
    “…However, the hypothesis of a major natural disaster was rarely suggested up to now, while field evidence points to the occurrence of a very large tsunami in the past, including the presence of numerous megablocks that were deposited by a “red wave” (or peau kula, which also mean tsunami in the Tongan language) according to a local myth. …”
  12. 35532

    Amino acid substitutions within SARS-CoV-2 Spike RBD may have contributed to zoonotic emergence. by Carina Conceicao (9904159)

    Published 2020
    “…The data points shown are the mean cell–cell fusion results seen in 3 completely independent experiments (green, increased relative activity; red, decreased relative activity). …”
  13. 35533
  14. 35534

    Image_5_Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity.jpeg by Francesca Faustini (204803)

    Published 2022
    “…A sub-cluster of PD-1<sup>high</sup>CD4+ T cells showed a significant decrease at later follow-up compared to early follow-up (p=0.0039). …”
  15. 35535

    Long-Term Clinical and Hemodynamic Outcomes after Heart Transplantation in Patients Pre-Treated with Sildenafil by Sofia Lázaro Mendes (7888673)

    Published 2021
    “…Results After treatment with sildenafil but before HT, PVR (-39%) and sPAP (-10%) decreased significantly. sPAP decreased after HT in both groups, but it remained significantly higher in group A vs. group B (40.3 ± 8.0 mmHg vs 36.5 ± 11.5 mmHg, p=0.022). …”
  16. 35536

    Data_Sheet_2_His-Ala-Phe-Lys peptide from Burkholderia arboris possesses antifungal activity.xlsx by Huajie Zhu (2228854)

    Published 2022
    “…Furthermore, a comparison of the differential metabolites between wild type B. arboris and the ∆cobA mutant showed a significantly decreased level of tetrapeptide His-Ala-Phe-Lys (Hafk) in the ∆cobA mutant. …”
  17. 35537

    Data_Sheet_1_His-Ala-Phe-Lys peptide from Burkholderia arboris possesses antifungal activity.docx by Huajie Zhu (2228854)

    Published 2022
    “…Furthermore, a comparison of the differential metabolites between wild type B. arboris and the ∆cobA mutant showed a significantly decreased level of tetrapeptide His-Ala-Phe-Lys (Hafk) in the ∆cobA mutant. …”
  18. 35538
  19. 35539

    Fig 3 - by Jannes Jegminat (8856635)

    Published 2022
    “…<b>(C)</b> The change of the mean of the filtering distribution as a function of the temporal difference between a pre-post spike pair. …”
  20. 35540

    Metabolic syndrome network visualizing cardiovascular risk factor burden, clustering, and flow of its components between baseline and five-year follow-up. by Robin Haring (149871)

    Published 2013
    “…<p>“<b>Healthy</b>”, no prevalent metabolic syndrome component; “<b>Obesity</b>”, waist circumference: men <u>></u>94 cm, women <u>></u> 80 cm; “<b>Glucose</b>”, elevated non-fasting glucose: ≥8.0 mmol/l or antidiabetic treatment (anatomic-therapeutical-chemical [ATC] codes A10A, A10B); “<b>HDL</b>”, decreased high-density lipoprotein cholesterol: men <1.0 mmol/l, women <1.3 mmol/l, or lipid-lowering treatment (ATC C10AB, A10AD); “<b>TG</b>”, elevated non-fasting triglycerides: ≥2.3 mmol/l or lipid-lowering treatment (ATC C10AB, A10AD); “<b>BP</b>”, elevated blood pressure: ≥130/85 mmHg or antihypertensive drug treatment. …”